Eknoyan G, Lameire N, Eckardt K, Kasiske B, Wheeler D, Levin A, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney int. 2013;3(1):5–14.

Google Scholar 

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Supplements. 2022;12(1):7–11.

Article  Google Scholar 

Fasipe OJ, Akhideno PE, Ibiyemi-Fasipe OB, Idowu AA. The burden of polypharmacy and pattern of comorbidities among chronic kidney disease patients in clinical practice. Archives Med Health Sci. 2018;6(1):40–7.

Article  Google Scholar 

Heimbürger O, Qureshi AR, Blaner WS, Berglund L, Stenvinkel P. Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis. 2000;36(6):1213–25.

Article  PubMed  Google Scholar 

Titze S, Schmid M, Köttgen A, Busch M, Floege J, Wanner C, et al. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German chronic kidney disease (GCKD) cohort. Nephrol Dialysis Transplantation. 2015;30(3):441–51.

Article  Google Scholar 

THIS HTC. Prevalence of comorbidities, polypharmacy and drug related problems among hospitalized patients with chronic kidney disease. 2023.

Mason NA, Bakus JL, editors. Strategies for reducing polypharmacy and other medication-related problems in chronic kidney disease. Seminars in dialysis. Wiley Online Library; 2010.

Laville SM, Metzger M, Stengel B, Jacquelinet C, Combe C, Fouque D, et al. Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort. Br J Clin Pharmacol. 2018;84(12):2811–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmidt IM, Hübner S, Nadal J, Titze S, Schmid M, Bärthlein B, et al. Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German chronic kidney Disease study. Clin Kidney J. 2019;12(5):663–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kadam UT, Roberts I, White S, Bednall R, Khunti K, Nilsson PM, et al. Conceptualizing multiple drug use in patients with comorbidity and multimorbidity: proposal for standard definitions beyond the term polypharmacy. J Clin Epidemiol. 2019;106:98–107.

Article  PubMed  Google Scholar 

Varghese D, Ishida C, Koya HH. Polypharmacy. StatPearls [Internet]. 2022.

Sutaria A, Liu L, Ahmed Z. Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective. Ther Adv Cardiovasc Dis. 2016;10(4):242–50.

Article  PubMed  PubMed Central  Google Scholar 

Liu M, Li X-C, Lu L, Cao Y, Sun R-R, Chen S, et al. Cardiovascular disease and its relationship with chronic kidney disease. Eur Rev Med Pharmacol Sci. 2014;18:19.

Google Scholar 

Riemer E, Werling E, Kribs M, Hamman De Compte A, Dimitrov Y. Medical prescriptions in haemodialysis patients: critical analysis. Néphrologie Thérapeutique. 2005;1(4):234–40.

Article  PubMed  Google Scholar 

Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, et al. Guidelines for the management of chronic kidney disease. CMAJ. 2008;179(11):1154–62.

Article  PubMed  PubMed Central  Google Scholar 

Wheeler DC, Winkelmayer WC. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) foreword. Kidney Int Supplements. 2017;7(1):1–59.

Article  Google Scholar 

Whittaker CF, Fink JC. Deprescribing in CKD: the proof is in the process. Am J Kidney Dis. 2017;70(5):596–8.

Article  PubMed  Google Scholar 

Mason NA. Polypharmacy and medication-related complications in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011;20(5):492–7.

Article  PubMed  Google Scholar 

Kimura H, Tanaka K, Saito H, Iwasaki T, Oda A, Watanabe S, et al. Association of polypharmacy with kidney disease progression in adults with CKD. Clin J Am Soc Nephrol. 2021;16(12):1797–804.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naseralallah L, Khatib M, Al-Khulaifi A, Danjuma M. Prevalence and global trends of polypharmacy in patients with chronic kidney disease: a systematic review and meta-analysis. Front Pharmacol. 2023;14:1122898.

Article  PubMed  PubMed Central  Google Scholar 

Zeleke TK, Birhan TY, Abdela OA. Medicine dose adjustment practice and associated factors among renally impaired patients in Amhara Regional State, Ethiopia. Int J Nephrol. 2021;2021:1–9.

Article  Google Scholar 

Wang X, Yang C, Jiang J, Hu Y, Hao Y, Dong J-Y. Polypharmacy, chronic kidney disease, and mortality among older adults: a prospective study of National Health and nutrition examination survey, 1999–2018. Front Public Health. 2023;11:1116583.

Article  PubMed  PubMed Central  Google Scholar 

Cockcroft DW, Gault H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.

Article  CAS  PubMed  Google Scholar 

Kelly JT, Su G, Zhang L, Qin X, Marshall S, González-Ortiz A, et al. Modifiable lifestyle factors for primary prevention of CKD: a systematic review and meta-analysis. J Am Soc Nephrol. 2021;32(1):239–53.

Article  CAS  PubMed  Google Scholar 

Rama M, Viswanathan G, Acharya LD, Attur R, Reddy P, Raghavan S. Assessment of drug-drug interactions among renal failure patients of nephrology ward in a south Indian tertiary care hospital. Indian J Pharm Sci. 2012;74(1):63.

Article  PubMed  PubMed Central  Google Scholar 

Marquito AB, Fernandes NMS, Colugnati FAB, Paula RB. Identifying potential drug interactions in chronic kidney disease patients. Brazilian J Nephrol. 2014;36:26–34.

Article  Google Scholar 

Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim care: Clin Office Pract. 2008;35(2):329–44.

Article  Google Scholar 

van Oosten MJ, Logtenberg SJ, Hemmelder MH, Leegte MJ, Bilo HJ, Jager KJ, et al. Polypharmacy and medication use in patients with chronic kidney disease with and without kidney replacement therapy compared to matched controls. Clin Kidney J. 2021;14(12):2497–523.

Article  PubMed  PubMed Central  Google Scholar 

Roux-Marson C, Baranski JB, Fafin C, Exterman G, Vigneau C, Couchoud C, et al. Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease. BMC Geriatr. 2020;20:1–12.

Article  Google Scholar 

Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:1–10.

Article  Google Scholar 

Sgnaolin V, Sgnaolin V, Engroff P, De Carli GA, Figueiredo AEPL. Assessment of used medications and drug-drug interactions among chronic renal failure patients. Scientia Med. 2014;24(4):2.

Google Scholar 

Al-Hajje A, Atoui F, Awada S, Rachidi S, Zein S, Salameh P, editors. Drug-related problems identified by clinical pharmacist’s students and pharmacist’s interventions. Annales pharmaceutiques françaises. Elsevier; 2012.

Cabello-Muriel A, Gascón–Cánovas JJ, Urbieta-Sanz E, Iniesta-Navalón C. Effectiveness of pharmacist intervention in patients with chronic kidney disease. Int J Clin Pharm. 2014;36:896–903.

Article  PubMed  Google Scholar 

Shemeikka T, Bastholm-Rahmner P, Elinder C-G, Vég A, Törnqvist E, Cornelius B, et al. A health record integrated clinical decision support system to support prescriptions of pharmaceutical drugs in patients with reduced renal function: design, development and proof of concept. Int J Med Informatics. 2015;84(6):387–95.

Article  Google Scholar 

Yao C-A, Chen Y-C, Lai C-Y, Lin C-H. Case Report Eefooton adjuvant therapy for diabetic nephropathy, heart failure, and pulmonary effusion: a case report and literature review. Int J Clin Exp Med. 2022;15(2):68–73.

Google Scholar 

Laville SM, Gras-Champel V, Moragny J, Metzger M, Jacquelinet C, Combe C, et al. Adverse drug reactions in patients with CKD. Clin J Am Soc Nephrol. 2020;15(8):1090–102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Getachew H, Tadesse Y, Shibeshi W. Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. BMC Nephrol. 2015;16:1–9.

Article  Google Scholar 

Onyedikachi EA, Ogochukwu AM, Chinwendu AK. Evaluation of drug-drug interactions among chronic kidney disease patients of nephrology unit in the University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State. J Basic Clin Pharm. 2017;8(0):49–53.

Google Scholar 

Okoro RN, Farate VT. The use of nephrotoxic drugs in patients with chronic kidney disease. Int J Clin Pharm. 2019;41:767–75.

Article  CAS  PubMed  Google Scholar 

Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.